A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency

Secondary antibody deficiency (SAD) is a common complication in chronic lymphocytic leukemia (CLL) which favors the development of life-threatening infections. Subcutaneous immunoglobulins (IG) (SCIG) have been proven to be as effective as intravenous immunoglobulin (IVIG) in primary immunodeficienc...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	secondary immunodeficiency intravenous immunoglobulin subcutaneous immunoglobulin chronic lymphocytic leukemia replacement therapy
Online Access:	https://www.mdpi.com/1718-7729/30/1/22